Global Stroke Management Market Is Estimated To Witness Significant Growth Due To Increasing Incidence Of Chronic Diseases

Stroke Management Market

Overview:

Ischemic strokes are caused by clots in the arteries that supply blood to the brain. These clots can be formed in the carotid arteries or vertebral arteries. Treatment for ischemic strokes depends on the cause. Hemorrhagic strokes occur when blood clots block the small blood vessels that carry oxygen-rich blood to the brain. Symptoms of hemorrhagic strokes include weakness, numbness or paralysis. Rehabilitation and therapy for people who have a stroke are important parts of long-term stroke care. These therapies can help in recovering physical, cognitive and emotional functions that were lost after the stroke.

Market Dynamics:

Rising product launches are estimated to augment growth of the global Stroke Management Market during the forecast period. For instance, a next-generation balloon guide catheter EMBOGUARD, was launched by CERENOVUS in February 2022. This catheter can be used in endovascular procedures, for patients suffering from acute ischemic stroke. Moreover, high cost of treatment is anticipated to restrain growth of the global stroke management market during the forecast period.

Impact of COVID-19:

The pandemic was first reported in 2019 in China. The pandemic later spread to other nations globally. The healthcare sector was severely affected, as the number of patients were increasing rapidly and there was a shortage of drugs and medical supplies globally. During the pandemic there was an increased demand for stroke management drugs, due to increased prevalence of stroke as a result of COVID-19. This led to growing demand for drugs and manufacturers had to increase their production volume. Thus, the pandemic had a positive impact on the growth of the global Stroke Management Market.

Key Takeaways:

 

The global Stroke Management Market is expected to witness high growth, exhibiting CAGR of 7.5% over the forecast period, due to growing product approvals. For instance, Medtronic gained emergency authorization from the US FDA in April 2020, for selling compact ventilator in the U.S.

 

North America is anticipated to witness robust growth in the global Stroke Management Market during the forecast period, due to rising awareness associated with symptoms and prevention of stroke and growing R&D activities.

 

Key players active in the global stroke management market are Siemens AG, Abbott Laboratories, Merck and Co. Inc., B Braun Melsungen AG, Medtronic Plc, Boston Scientific Corporation, General Electric Company, Bristol Myers Squibb Co., and Cardinal Health Inc.